Correlation Between Sonnet Biotherapeutics and Ocugen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Ocugen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Ocugen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Ocugen Inc, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Ocugen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Ocugen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Ocugen.

Diversification Opportunities for Sonnet Biotherapeutics and Ocugen

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Sonnet and Ocugen is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Ocugen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocugen Inc and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Ocugen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocugen Inc has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Ocugen go up and down completely randomly.

Pair Corralation between Sonnet Biotherapeutics and Ocugen

Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to under-perform the Ocugen. But the stock apears to be less risky and, when comparing its historical volatility, Sonnet Biotherapeutics Holdings is 1.03 times less risky than Ocugen. The stock trades about -0.05 of its potential returns per unit of risk. The Ocugen Inc is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  39.00  in Ocugen Inc on August 26, 2024 and sell it today you would earn a total of  52.00  from holding Ocugen Inc or generate 133.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Sonnet Biotherapeutics Holding  vs.  Ocugen Inc

 Performance 
       Timeline  
Sonnet Biotherapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sonnet Biotherapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Ocugen Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ocugen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Sonnet Biotherapeutics and Ocugen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sonnet Biotherapeutics and Ocugen

The main advantage of trading using opposite Sonnet Biotherapeutics and Ocugen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Ocugen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocugen will offset losses from the drop in Ocugen's long position.
The idea behind Sonnet Biotherapeutics Holdings and Ocugen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges